Form 4: BlackRock Health Sciences Manager's Equity Changes

BlackRock Health Sciences Term Trust's Portfolio Manager, Liu Xiang, reported vesting and cash settlement of phantom shares.

Summary

• Portfolio Manager Liu Xiang reported transactions on January 30, 2026, involving both common stock and phantom shares.
• 777.9221 shares of common stock were acquired through the exercise of derivative securities and immediately disposed of at a price of $15.21 per share, resulting in zero direct beneficial ownership of common stock after the transaction.
• This common stock transaction represents the cash settlement of previously vested phantom shares.
• New phantom shares totaling 1,026.693 were acquired, which are scheduled to vest in equal installments on each of the first three anniversaries of the award date.
• An additional 523.331 phantom shares from a January 31, 2025 grant and 254.5911 phantom shares from a January 31, 2024 grant also vested.
• Phantom shares are the economic equivalent of one share of common stock and become payable in cash upon vesting.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting routine executive compensation and retention mechanisms, which are generally healthy for corporate governance and management alignment.

Positives

• Portfolio Manager Liu Xiang received cash settlement for vested phantom shares, representing a realized compensation benefit.
• The grant of new phantom shares aligns management incentives with the long-term performance of BlackRock Health Sciences Term Trust.

Future Outlook

Phantom shares granted on January 30, 2026, are scheduled to vest in equal installments over the next three years. Remaining phantom shares from grants on January 31, 2025, and January 31, 2024, will continue to vest in equal installments on their respective anniversaries, leading to future cash payments to the reporting person.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, reflecting routine compensation events like equity vesting and subsequent cash settlement. This is common practice across the investment management industry for aligning portfolio managers' interests with fund performance and retaining key talent.

Comparison to Industry Standards

• The use of phantom shares with multi-year vesting schedules is a common practice in the financial industry to incentivize long-term performance and retention of key personnel.
• This compensation structure aligns with practices seen at major asset management firms like Vanguard or Fidelity for their fund managers, where performance-based equity or equity-equivalent awards are standard components of executive compensation.

Related Party Transactions

• The vesting and settlement of phantom shares for Portfolio Manager Liu Xiang represent a standard compensation arrangement between BlackRock Health Sciences Term Trust and a key executive.

Stakeholder Impact

• Shareholders: The impact is generally neutral, as these are routine compensation events that are part of expected operational costs and incentive structures.
• Employees (specifically Liu Xiang): Positive impact due to the cash settlement of vested equity and the grant of new phantom shares as part of their compensation package.

Next Steps

• Future vesting of phantom shares granted on January 30, 2026, on their first, second, and third anniversaries.
• Future vesting of remaining phantom shares from January 31, 2025, and January 31, 2024, grants on their respective anniversaries.

Key Dates

Recommendation

This Form 4 filing details routine insider compensation related to phantom share vesting and cash settlement. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It's a standard disclosure reflecting ongoing executive compensation practices.

Keywords

BlackRock, BMEZ, Form 4, insider transaction, beneficial ownership, phantom shares, executive compensation, portfolio manager